These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21557663)

  • 1. Novel cholesteryl ester transfer protein inhibitors: promising therapy for dyslipidemia?
    Devaraj S; Jialal I
    Metab Syndr Relat Disord; 2011 Jun; 9(3):163-5. PubMed ID: 21557663
    [No Abstract]   [Full Text] [Related]  

  • 2. Anacetrapib and dalcetrapib: two novel cholesteryl ester transfer protein inhibitors.
    Miyares MA
    Ann Pharmacother; 2011 Jan; 45(1):84-94. PubMed ID: 21205945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-density lipoprotein lowering in 2013 by nonstatin agents: the discovery and development of promising novel targeted therapies.
    Kohli P; Giugliano RP
    J Cardiovasc Pharmacol Ther; 2013 May; 18(3):199-210. PubMed ID: 23580658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The DEFINE study: a bright future for CETP inhibitors?
    Katsiki N; Athyros VG; Mikhailidis DP
    Expert Opin Investig Drugs; 2011 Mar; 20(3):311-4. PubMed ID: 21235422
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of cholesteryl ester transfer protein inhibitor on vitamin E transport should be studied.
    Masterjohn C
    Am Heart J; 2009 Jul; 158(1):e11; author reply e13. PubMed ID: 19540377
    [No Abstract]   [Full Text] [Related]  

  • 6. Treating high-density lipoprotein cholesterol: a return to inhibition of cholesteryl ester transfer protein?
    Duriez P
    Curr Atheroscler Rep; 2008 Jun; 10(3):177-9. PubMed ID: 18489843
    [No Abstract]   [Full Text] [Related]  

  • 7. Trial watch: hope renewed for strategy to raise HDL cholesterol.
    Nat Rev Drug Discov; 2011 Jan; 10(1):10. PubMed ID: 21193857
    [No Abstract]   [Full Text] [Related]  

  • 8. CETP inhibition.
    Duriez P
    Lancet; 2007 Dec; 370(9603):1882-3. PubMed ID: 18068495
    [No Abstract]   [Full Text] [Related]  

  • 9. Anacetrapib: a potential new therapy for dyslipidemia.
    Robinson LB; Frishman WH
    Cardiol Rev; 2014; 22(5):253-61. PubMed ID: 24618931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anacetrapib: a new weapon against dyslipidemia.
    Aperis G; Paliouras C; Tsampikaki E; Papakonstantinou N; Alivanis P
    Curr Clin Pharmacol; 2011 Nov; 6(4):227-35. PubMed ID: 22082322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Journey through cholesteryl ester transfer protein inhibition: from bench to bedside.
    Karalis I; Rensen PC; Jukema JW
    Circ Cardiovasc Qual Outcomes; 2013 May; 6(3):360-6. PubMed ID: 23674310
    [No Abstract]   [Full Text] [Related]  

  • 12. Anacetrapib.
    Am J Cardiovasc Drugs; 2010; 10(4):267-70. PubMed ID: 20653333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Success, Failure, and Transparency in Biomarker-Based Drug Development: A Case Study of Cholesteryl Ester Transfer Protein Inhibitors.
    Hey SP; Franklin JM; Avorn J; Kesselheim AS
    Circ Cardiovasc Qual Outcomes; 2017 Jun; 10(6):. PubMed ID: 28611186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular targeting therapy of dyslipidemia].
    Hara M; Kinoshita M
    Nihon Rinsho; 2012 Nov; 70 Suppl 8():618-22. PubMed ID: 23513913
    [No Abstract]   [Full Text] [Related]  

  • 15. Good news for 'good' cholesterol.
    Katsnelson A
    Nature; 2010 Nov; 468(7322):354. PubMed ID: 21085143
    [No Abstract]   [Full Text] [Related]  

  • 16. Cholesteryl ester transfer protein inhibitors as high-density lipoprotein raising agents.
    Shinkai H
    Expert Opin Ther Pat; 2009 Sep; 19(9):1229-37. PubMed ID: 19663630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-density lipoprotein cholesterol: current perspective for clinicians.
    Whayne TF
    Angiology; 2009; 60(5):644-9. PubMed ID: 19240106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cholesterol ester transfer protein inhibitor, anacetrapib.
    Jialal I; Kaur J
    Curr Opin Lipidol; 2011 Jun; 22(3):245-6. PubMed ID: 21562390
    [No Abstract]   [Full Text] [Related]  

  • 19. Different effects of compounds decreasing cholesteryl ester transfer protein activity on lipoprotein metabolism.
    Niesor EJ
    Curr Opin Lipidol; 2011 Aug; 22(4):288-95. PubMed ID: 21587074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of the new frontiers in the treatment of atherogenic dyslipidemias.
    Rached FH; Chapman MJ; Kontush A
    Clin Pharmacol Ther; 2014 Jul; 96(1):57-63. PubMed ID: 24727469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.